300199 翰宇藥業
按盤價 
10.450 +0.700 (+7.179%)
10.450 +0.700 (+7.179%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -1.369 | -50.642 | -25.955 | 1.912 | -31.530 |
| 總資產報酬率 ROA (%) | -0.328 | -14.920 | -9.858 | 0.777 | -13.938 |
| 投入資產回報率 ROIC (%) | -0.379 | -17.110 | -11.247 | 0.873 | -17.055 | 邊際利潤分析 |
| 銷售毛利率 (%) | 60.086 | 49.306 | 77.336 | 72.042 | 80.478 |
| 營業利潤率 (%) | -1.062 | -117.646 | -52.647 | 5.313 | -79.581 |
| 息稅前利潤/營業總收入 (%) | 21.142 | -89.442 | -37.669 | 17.970 | -73.278 |
| 淨利潤/營業總收入 (%) | -4.290 | -119.486 | -52.895 | 3.864 | -84.423 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 1,403.965 | 89.426 | 59.104 | -701.260 | 29.018 |
| 價值變動淨收益/利潤總額(%) | 4.760 | -6.790 | 24.078 | 1,105.394 | -1.447 |
| 營業外收支淨額/利潤總額(%) | 28.846 | 0.704 | 0.539 | -16.096 | 2.360 | 償債能力分析 |
| 流動比率 (X) | 0.422 | 0.480 | 0.708 | 1.553 | 0.954 |
| 速動比率 (X) | 0.235 | 0.373 | 0.542 | 1.342 | 0.784 |
| 資產負債率 (%) | 74.256 | 76.101 | 64.086 | 57.813 | 58.264 |
| 帶息債務/全部投入資本 (%) | 66.450 | 68.751 | 55.195 | 49.725 | -- |
| 股東權益/帶息債務 (%) | 43.313 | 38.717 | 72.944 | 92.826 | 86.754 |
| 股東權益/負債合計 (%) | 33.516 | 30.425 | 54.904 | 70.167 | 69.909 |
| 利息保障倍數 (X) | 0.934 | -3.080 | -2.468 | 1.342 | -8.907 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 95.113 | 189.181 | 148.743 | 143.063 | 0.000 |
| 存貨周轉天數 (天) | 311.326 | 281.953 | 391.397 | 300.840 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 27/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
